Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience Inks Exclusive Distribution Deal With Ireland's MyBio

NEW YORK – MyBio said on Thursday that it has signed an agreement to become Twist Bioscience's exclusive distributor in Ireland.

Kilkenny, Ireland-based MyBio will provide Twist's synthetic DNA and next-generation sequencing products to the Irish market. Financial and other details of the deal were not disclosed.

The relationship adds to a handful of distribution agreements that Twist has signed. In 2018, the South San Francisco, California-based firm announced deals for Japan, South Korea, India, Hong Kong, and Macau.

In 2013, Promega signed MyBio as its Ireland distributor.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.